BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 11344347)

  • 1. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
    Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
    J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled NO and eosinophil markers in blood, nasal lavage and sputum in children with asthma after withdrawal of budesonide.
    Lönnkvist K; Anderson M; Hedlin G; Svartengren M
    Pediatr Allergy Immunol; 2004 Aug; 15(4):351-8. PubMed ID: 15305945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma.
    Covar RA; Szefler SJ; Martin RJ; Sundstrom DA; Silkoff PE; Murphy J; Young DA; Spahn JD
    J Pediatr; 2003 May; 142(5):469-75. PubMed ID: 12756375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis.
    Orhan F; Sekerel BE; Adalioglu G; Pinar M; Tuncer A
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte proteins in serum in childhood asthma: relation to spirometry and therapy.
    Scher H; Berman D; Weinberg EG; Schinkel M; Peper B; Chalton DO; Potter PC
    Clin Exp Allergy; 1996 Oct; 26(10):1131-41. PubMed ID: 8911698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Airway function correlates with circulating eosinophil, but not mast cell, markers of inflammation in childhood asthma.
    Rao R; Frederick JM; Enander I; Gregson RK; Warner JA; Warner JO
    Clin Exp Allergy; 1996 Jul; 26(7):789-93. PubMed ID: 8842552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asthma, bronchial hyperreactivity and mediator release in children with birch pollinosis. ECP and EPX levels are not related to bronchial hyperreactivity.
    Ferdousi HA; Dreborg S
    Clin Exp Allergy; 1997 May; 27(5):530-9. PubMed ID: 9179427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma.
    Wever AM; Wever-Hess J; Hermans J
    Clin Exp Allergy; 1997 May; 27(5):519-29. PubMed ID: 9179426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B; Aydemir C; Ustündag G; Eldeş N; Kutsal E; Can M; Demirtaş S; Tomaç N
    Turk J Pediatr; 2009; 51(5):460-5. PubMed ID: 20112601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of association of peripheral blood eosinophilia or increased eosinophil cationic protein with bronchial hyperresponsiveness during asthma remission.
    Koh YY; Kang H; Nah KM; Kim CK
    Ann Allergy Asthma Immunol; 2003 Sep; 91(3):297-302. PubMed ID: 14533663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of blood eosinophilia and the eosinophil cationic protein (ECP) in the serum of asthmatic children with varying degree of severity.
    Vilá-Indurain B; Muñoz-López F; Martín-Mateos M
    Allergol Immunopathol (Madr); 1999; 27(6):304-8. PubMed ID: 10611555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking.
    Pedersen B; Dahl R; Karlström R; Peterson CG; Venge P
    Am J Respir Crit Care Med; 1996 May; 153(5):1519-29. PubMed ID: 8630596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of allergic inflammation in peripheral blood of children with asthma after treatment with inhaled triamcinolone acetonide.
    Stelmach I; Jerzynska J; Kuna P
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):319-26. PubMed ID: 11686425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and application of induced sputum analysis in childhood asthma.
    Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
    J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchial responsiveness to methacholine and adenosine 5'-monophosphate in young children with asthma: their relationship with blood eosinophils and serum eosinophil cationic protein.
    Choi SH; Kim DK; Yu J; Yoo Y; Koh YY
    Allergy; 2007 Oct; 62(10):1119-24. PubMed ID: 17573858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is serum ECP level helpful in determining discontinuation of inhaled corticosteroid therapy in asthmatic children?
    Bahceciler NN; Basdemir D; Nursoy AM; Nuhoğlu Y; Barlan IB; Basaran MM
    Allergol Immunopathol (Madr); 2000; 28(5):278-82. PubMed ID: 11270089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children.
    Strunk RC; Szefler SJ; Phillips BR; Zeiger RS; Chinchilli VM; Larsen G; Hodgdon K; Morgan W; Sorkness CA; Lemanske RF;
    J Allergy Clin Immunol; 2003 Nov; 112(5):883-92. PubMed ID: 14610474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum eosinophil cationic protein as a predictor of disease activity in acute and chronic asthma.
    Onadeko BO; Khadadah ME; Mustafa HT; Ezeamuzie CI; Marouf R; Khamis A; Sugathan TN
    East Afr Med J; 1999 Sep; 76(9):524-9. PubMed ID: 10685325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil soluble protein levels, eosinophil peroxidase and eosinophil cationic protein in asthmatic patients.
    Parra A; Sanz ML; Vila L; Prieto I; Diéguez I; Oehling AK
    J Investig Allergol Clin Immunol; 1999; 9(1):27-34. PubMed ID: 10212854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitivity of sputum eosinophil cationic protein level for monitoring asthmatic patients with normal peak expiratory flow].
    Nakazawa T; Kagami M; Matumura R; Kawashima T; Matuzuwa Y; Takada M
    Arerugi; 1999 Oct; 48(10):1153-60. PubMed ID: 10554401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.